Hemodynamic and Pharmacokinetic Interactions of TPN171 with Alcohol in Healthy Male Subjects

Documenti analoghi

• Safety, Tolerability, and Pharmacokinetics of SC1011 (Sufenidone), a Novel Antifibrotic Small Molecule, in Phase 1 Studies in Healthy Subjects
  di: Yun Liu, et al.
  Pubblicazione: (2025)
• Safety, pharmacokinetics, and pharmacodynamics in healthy Chinese volunteers treated with SC0062, a highly selective endothelin‐A receptor antagonist
  di: Yun Liu, et al.
  Pubblicazione: (2024)
• First‐in‐Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASP1617, a Cathepsin‐S Inhibitor, in Healthy Adult Subjects
  di: Tomoki Kojima, et al.
  Pubblicazione: (2026)
• Pharmacokinetics and Safety of Fixed‐Dose Versus Separate Enavogliflozin/Gemigliptin Combinations, and Food Effect on Enavogliflozin in Healthy Korean Subjects
  di: Young‐Sim Choi, et al.
  Pubblicazione: (2025)
• Pharmacokinetics and Safety of Single and Multiple Doses of Molnupiravir in Healthy Male Chinese Adults: An Open‐Label, Fixed Sequence, Phase 1 Study
  di: Jixiang Zhu, et al.
  Pubblicazione: (2026)